Atlas Trials

The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With U-500 Insulin

Clinical trial NCT02597309 · WITHDRAWN

Trial details

NCT number
NCT02597309
Sponsor
Joslin Diabetes Center
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes, Obesity
Start date
2015-11-01
Primary completion
2017-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.